{"id":31817,"date":"2024-09-04T13:50:00","date_gmt":"2024-09-04T18:50:00","guid":{"rendered":"https:\/\/ustower.net\/?p=31817"},"modified":"2024-09-04T19:56:41","modified_gmt":"2024-09-05T00:56:41","slug":"jj-loses-1-billion-court-ruling-on-surgical-robot-deal","status":"publish","type":"post","link":"https:\/\/ustower.net\/?p=31817","title":{"rendered":"J&#038;J Loses $1 Billion Court Ruling on Surgical Robot Deal"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">Johnson &amp; Johnson&nbsp;was hit with more than $1 billion in damages Wednesday for breaching its pledge to prioritize two surgical robots it acquired when it bought&nbsp;<a href=\"https:\/\/www.bloomberglaw.com\/company\/ticker\/0920776D US Equity\">Auris Health Inc.<\/a>&nbsp;for $3.4 billion.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">A Delaware judge ruled against the pharmaceutical giant eight months after a trial of claims that it engaged in wide-ranging breaches of its agreement with former Auris shareholders by failing to pursue regulatory approvals for two projects with blockbuster potential, the iPlatform and the Monarch.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">More than $2 billion in additional payments hinged on the approvals. The allegations echoed a recurring theme in Delaware\u2019s Chancery Court, the leading US forum for M&amp;A fights, where it\u2019s common for lawsuits to assert that corporate acquirers are trying to wriggle out of post-deal payments.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">\u201cJ&amp;J\u2019s promise to Auris was broken almost immediately,\u201d Vice Chancellor Lori W. Will said in a 145-page opinion. Although the damages will compensate the Auris ex-investors, \u201cwhat remains irretrievably lost is the transformative potential of Auris\u2019 robots,\u201d Will said.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">The company criticized the ruling through a spokesperson Wednesday, stressing in a statement that it had \u201cno bearing on our current robotics program or our Ottava system that we plan to bring to market.\u201d<\/p>\n\n\n\n<p class=\"has-medium-font-size\">\u201cWe respectfully disagree with the court\u2019s decision regarding our development of the iPlatform and communications with Auris regarding soft tissue ablation,\u201d the statement said. \u201cFundamentally, the court viewed our commercially reasonable contract as imposing a commercially unreasonable obligation. We are reviewing the decision and assessing our options for appeal.\u201d<\/p>\n\n\n\n<p class=\"has-medium-font-size\">The lawsuit, filed in 2020, said J&amp;J misled Auris before the 2019 transaction about how it would allocate resources between the iPlatform and the \u201cVerb,\u201d a rival robot already being developed in partnership with a&nbsp;Google&nbsp;affiliate. J&amp;J held a \u201cfaceoff\u201d competition between the two systems called \u201cProject Manhattan\u201d to determine which would move forward, according to Wednesday\u2019s ruling.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Because the Verb had a significant head start, J&amp;J knew the approach \u201cwould hinder, rather than promote, iPlatform\u2019s achievement of regulatory milestones\u201d by forcing its developers to devote all their resources to playing catchup, Will said. Although the iPlatform prevailed in the competition, it won a Pyrrhic victory, she found.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">\u201cFor iPlatform, winning Project Manhattan was losing,\u201d as it \u201ceffectively became a parts shop for Verb,\u201d the judge said. \u201cBut J&amp;J viewed the resulting delays as beneficial since it could avoid making the earnout payment. When J&amp;J\u2019s actions put the first iPlatform milestone out of reach, the other milestones fell like dominos.\u201d<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Will did rule for J&amp;J on certain issues, largely rejecting contract claims involving the other device, the Monarch, and fraud allegations centering on the idea that J&amp;J deliberately duped Auris into accepting deferred payments it never had any intention of making. But she handed the former shareholders a win on one fraud count involving the Monarch.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">The Auris ex-investors include the company\u2019s founder, a pioneer in the field who previously started&nbsp;Intuitive Surgical Inc., manufacturer of the industry-leading Da Vinci surgical robot.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Ross Aronstam &amp; Moritz LLP and Selendy Gay PLLC are counsel for the former Auris investors, who sued through a litigation representative. J&amp;J is represented by Morris, Nichols, Arsht &amp; Tunnell LLP and Patterson Belknap Webb &amp; Tyler LLP.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">The case is&nbsp;<a href=\"https:\/\/www.bloomberglaw.com\/public\/document\/CONFORDFortisAdvisorsLLCvJohnsonJohnsonetalDocketNo20200881DelChO\/5?doc_id=X70RFCQ2LEE9GBQAKIIJ8IN673E\">Fortis &amp; Fortis Advisors LLC v. Johnson &amp; Johnson<\/a>, Del. Ch., No. 2020-0881, 9\/4\/24.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><a href=\"https:\/\/news.bloomberglaw.com\/esg\/j-j-loses-1-billion-court-ruling-on-surgical-robot-acquisition\">bloomberglaw<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Johnson &amp; Johnson&nbsp;was hit with more than $1 billion in damages Wednesday for breaching its pledge to prioritize two surgical robots it acquired when it bought&nbsp;Auris Health Inc.&nbsp;for $3.4 billion. A Delaware judge ruled against the pharmaceutical giant eight months after a trial of claims that it engaged in wide-ranging breaches of its agreement with [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":31818,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1155],"tags":[24802,4975,30342,3721],"class_list":["post-31817","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-j-j","tag-lost","tag-surgical-robot","tag-trading"],"_links":{"self":[{"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts\/31817","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31817"}],"version-history":[{"count":1,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts\/31817\/revisions"}],"predecessor-version":[{"id":31819,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts\/31817\/revisions\/31819"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/media\/31818"}],"wp:attachment":[{"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31817"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31817"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31817"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}